About the project
In EUGeneHeart 21 partners from 10 European countries build a scientific research consortium with focus on signalling mechanisms with respect to heart failure. EUGeneHeart is a EU funded integrated research project.
Read more about the project
Read more about publications
After 5 years of EU funding, EUGeneHeart was successfully completed early in 2011.
Final General Assembly at Bibliothèque Solvay in Brussels, Belgium, from 2-4 December 2010.
APEIRON Biologics AG (Apeiron) will announce at BioSquare 2010 in Geneva the closing of a multi-million Euro out-licensing deal with one of the world's top-5 pharmaceutical companies.
EUGeneHeart - European Excellence project for heart research
European Union promotes with 11,4 million Euros - coordination in Göttingen.
TOP OF SITE
PRINT
